iSpecimen Inc.
ISPC
$1.25
$0.0352.88%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -42.70% | -4.17% | 76.22% | -22.38% | -13.05% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -42.70% | -4.17% | 76.22% | -22.38% | -13.05% |
| Cost of Revenue | -7.22% | 11.61% | 66.87% | -12.81% | 1.25% |
| Gross Profit | -86.81% | -20.03% | 86.56% | -28.46% | -26.04% |
| SG&A Expenses | 65.19% | -22.55% | -22.38% | -3.78% | 3.32% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 34.33% | -12.16% | -2.73% | -3.68% | 6.72% |
| Operating Income | -103.43% | 22.27% | 38.75% | -18.02% | -34.06% |
| Income Before Tax | -96.77% | 31.79% | 39.46% | -19.34% | -42.29% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -96.77% | 31.79% | 39.46% | -19.34% | -42.29% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -96.77% | 31.79% | 39.46% | -19.34% | -42.29% |
| EBIT | -103.43% | 22.27% | 38.75% | -18.02% | -34.06% |
| EBITDA | -105.57% | 24.18% | 39.92% | -17.29% | -31.73% |
| EPS Basic | 21.07% | 55.01% | 51.77% | -17.36% | -39.68% |
| Normalized Basic EPS | 21.07% | 55.01% | 51.77% | -17.36% | -39.68% |
| EPS Diluted | 21.07% | 55.01% | 51.77% | -17.36% | -38.82% |
| Normalized Diluted EPS | 21.07% | 55.01% | 51.77% | -17.36% | -39.68% |
| Average Basic Shares Outstanding | 149.29% | 51.58% | 25.53% | 1.69% | 1.86% |
| Average Diluted Shares Outstanding | 149.29% | 51.58% | 25.53% | 1.69% | 1.86% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |